703 filings
8-K
VTGN
VistaGen Therapeutics Inc
25 Apr 24
Vistagen Announces Positive Results from Phase 2A Pilot Study of PH15 for Improvement of Psychomotor Impairment Caused by Mental Fatigue
7:18pm
DEF 14A
VTGN
VistaGen Therapeutics Inc
Definitive proxy
15 Apr 24
9:52pm
PRE 14A
VTGN
VistaGen Therapeutics Inc
Preliminary proxy
5 Apr 24
5:29pm
8-K
VTGN
VistaGen Therapeutics Inc
1 Apr 24
Vistagen Initiates PALISADE-3 Phase 3 Study of Fasedienol for the Acute Treatment of Social Anxiety Disorder following Positive Results of PALISADE-2
5:25pm
4
Mary L. Rotunno
6 Mar 24
Vistagen Therapeutics / Mary L. Rotunno ownership change
6:00pm
4
Gin Jerry B
6 Mar 24
Vistagen Therapeutics / JERRY B GIN ownership change
6:00pm
4
Margaret M FitzPatrick
6 Mar 24
Vistagen Therapeutics / Margaret M FitzPatrick ownership change
6:00pm
4
VTGN
VistaGen Therapeutics Inc
6 Mar 24
Vistagen Therapeutics / Joanne Curley ownership change
6:00pm
4
VTGN
VistaGen Therapeutics Inc
6 Mar 24
Vistagen Therapeutics / Ann Michelle Cunningham ownership change
6:00pm
4
VTGN
VistaGen Therapeutics Inc
6 Mar 24
Vistagen Therapeutics / JON S SAXE ownership change
6:00pm
EFFECT
VTGN
VistaGen Therapeutics Inc
1 Mar 24
Notice of effectiveness
12:15am
SC 13G/A
Citadel Advisors LLC
14 Feb 24
Vistagen Therapeutics / CITADEL ADVISORS ownership change
6:18pm
SC 13G
Nantahala Capital Management, LLC
14 Feb 24
Vistagen Therapeutics / Nantahala Capital Management ownership change
4:51pm
SC 13G/A
VTGN
VistaGen Therapeutics Inc
14 Feb 24
Vistagen Therapeutics / GREAT POINT PARTNERS ownership change
4:39pm
SC 13G/A
Point72 Asset Management, L.P.
14 Feb 24
Vistagen Therapeutics / Point72 Asset Management ownership change
8:56am
SC 13G
VTGN
VistaGen Therapeutics Inc
13 Feb 24
Vistagen Therapeutics / VANGUARD ownership change
5:17pm
S-3
VTGN
VistaGen Therapeutics Inc
Shelf registration
13 Feb 24
4:52pm
8-K
VTGN
VistaGen Therapeutics Inc
13 Feb 24
Vistagen Reports Fiscal 2024 Third Quarter Financial Results and Provides Corporate Update
4:33pm
10-Q
2024 Q3
VTGN
VistaGen Therapeutics Inc
Quarterly report
13 Feb 24
4:25pm
8-K
VTGN
VistaGen Therapeutics Inc
8 Jan 24
Regulation FD Disclosure
6:37pm